参考文献/References:
[1] Baum JB, Fox PC, Neumann RD. The salivary glands.//Herbert JC,Eckelman WC, Neumann RD. Nuclear Medicine:Diagnosis and Therapy[M]. New York:Thieme Medical, 1996:439-444.
[2] 陈跃,Hongming Zhuang,杨吉刚.放射性核素唾液显像的临床应用进展[J].国际放射医学核医学杂志,2012,36(1):13-15.
[3] Tonami H, Higashi K, Matoba M, et al. A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome[J]. J Comput Assist Tomogr, 2001, 25(2):262-268.
[4] Booker J, Howarth D, Taylor L, et al. Appropriate utilization of semi-quantitative analysis in salivary scintigraphy[J]. Nucl Med Commun,2004,25(12):1203-1210.
[5] Adams BK, Al Attia HM, Parkar S. Salivary gland scintigraphy in Sjögren’s syndrome:are quantitative indices the answer?[J]. Nucl Med Commun, 2003, 24(9):1011-1016.
[6] Taura S, Murata Y, Aung W, et al. Decreased thyroid uptake of Tc99m pertechnetate in patients with advanced-stage Sjögren syndrome:evaluation using salivary gland scintigraphy[J]. Clin Nucl Med, 2002, 27 (4):265-269.
[7] Garcí:a-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome:clinical and immunologic disease patterns in a cohort of 400 patients[J]. Med(Baltimore), 2002, 81(24):270-280.
[8] Ramos-Canals M, Brito-Zeró:n P, Sisó:-Almirall A, et al. Primary Sjögren syndrome[J]. Praxis (Berm 1994), 2012, 101 (24):1565-1571.
[9] 林天生,王申,陈为民.99TcmO4-腮腺动态显像在干燥综合征诊断中的价值[J].海南医学院学报,2012,18(7):977-980.
[10] 宋晏,陈正福,张学敏,等.唾液腺核素显像在诊断干燥综合征中的临床意义[J].航空航天医学杂志,2013,24(12):1541-1542.
[11] 张晓明,冯压,张文军,等.核素唾液腺动态显像定量分析评价干燥综合征唾液腺功能的研究[J].中国医学影像技术,2007, 23(4):608-612.
[12] 谭立明,王外梅,樊有龙,等.干燥综合征患者特异性抗体的检测[J].江西医学检验,1997,15(2):11-13.
[13] 向阳,周陆.唾液腺动态显像定量分析对原发干燥综合征的诊断及评估病变程度的临床研究[J].中国全科医学,2013, 16(24):2809-2812.
相似文献/References:
[1]王立凯,黄丽娟,潘学继,等.人附睾蛋白4单克隆抗体与免放试剂盒的制备及其对卵巢癌诊断的临床价值探讨[J].国际放射医学核医学杂志,2016,40(3):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
Wang Likai,Huang Lijuan,Pan Xueji,et al.Preparation of monoclonal antibodies and immunoradiometric assay kit against human epididymis protein 4 and its clinical value in diagnosis of ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
[2]汪文霞,兰晓莉,张永学.HER2的表达及其分子影像的研究进展[J].国际放射医学核医学杂志,2016,40(5):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
Wang Wenxia,Lan Xiaoli,Zhang Yongxue.Research and development of HER2 expression molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
[3]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[4]郭艾楠,魏玲格,傅鹏.131I-肿瘤细胞核人鼠嵌合单克隆抗体治疗实体瘤的研究进展[J].国际放射医学核医学杂志,2013,37(2):120.[doi:10.3760/cma.j.issn.1673-4114.2013.02.015]
GUO Ai-nan,WEI Ling-ge,FU Peng.Advances on the treatment of solid tumor by 131I labeled mouse-human chimeric tumor necrosis therapy monoclanal antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):120.[doi:10.3760/cma.j.issn.1673-4114.2013.02.015]
[5]张建媛,缪蔚冰.电化学发光法与放射性受体分析法检测促甲状腺激素受体抗体的对比研究[J].国际放射医学核医学杂志,2012,36(1):20.[doi:10.3760/cma.j.issn.1673-4114.2012.01.005]
ZHANG Jian-yuan,MIAO Wei-bing.Comparative study between electrochemiluminescence immunoassay and radioactive receptor assay in measurement of serum thyrotropin receptor antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):20.[doi:10.3760/cma.j.issn.1673-4114.2012.01.005]
[6]姚红霞,张金山.微波消融和131I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌[J].国际放射医学核医学杂志,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
YAO Hong-xia,ZHA NG Jin-shan.Combination of microwave ablation and 131I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
[7]黄丽娟,王立凯,胡芳,等.肿瘤M2型-丙酮酸激酶单克隆抗体的制备及免疫放射分析方法的建立[J].国际放射医学核医学杂志,2012,36(3):134.[doi:10.3760/cma.j.issn.1673-4114.2012.03.002]
HUANG Li-juan,WANG Li-kai,HU Fang,et al.Preparation of the monoclonal antibodies against tumor M2-type pyruvate kinase and establishment of immunoradiometric analysis for detection[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):134.[doi:10.3760/cma.j.issn.1673-4114.2012.03.002]
[8]钟兴祥,郑吉祥,蓝冠章,等.Graves甲亢131I治疗前后血清TRAb动态变化及临床价值[J].国际放射医学核医学杂志,2011,35(2):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
ZHONG Xing-xiang,ZHENG Ji-xiang,LAN Guan-zhang,et al.Changes of serum TRAb after 131I radiotherapy in patients of Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):110.[doi:10.3760/cma.j.issn.1673-4114.2011.02.011]
[9]蒋宁一,熊玥.放射免疫导向治疗真菌感染灶的研究[J].国际放射医学核医学杂志,2008,32(3):137.
JIANG Ning-yi,XIONG Yue.Research about the radioimmunotherapy of fungal infection[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):137.
[10]李楠,李培勇.放射性碘间接标记抗体方法的研究进展[J].国际放射医学核医学杂志,2008,32(5):260.
LI Nan,LI Pei-yong.The recent development of the strategy for indirect antibody radiolabel with iodine[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):260.